Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

HC Wainwright & Co. Maintains Buy on Cogent Biosciences, Raises Price Target to $31

HC Wainwright & Co. analyst Michael King maintains Cogent Biosciences (NASDAQ:COGT) with a Buy and raises the price target from $25 to $31.
byBenzinga Newsdesk
November 5, 2021
1 minute read
Total
0
Shares
0
0
0
0
0
0

HC Wainwright & Co. analyst Michael King maintains Cogent Biosciences (NASDAQ:COGT) with a Buy and raises the price target from $25 to $31.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0